MASS icon

908 Devices

4.75 USD
+0.22
4.86%
At close Apr 17, 4:00 PM EDT
After hours
4.76
+0.01
0.21%
1 day
4.86%
5 days
24.02%
1 month
3.71%
3 months
59.40%
6 months
38.48%
Year to date
116.89%
1 year
-15.03%
5 years
-90.31%
10 years
-90.31%
 

About: 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Employees: 246

0
Funds holding %
of 7,407 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

45% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

5.61% less ownership

Funds ownership: 53.73% [Q3] → 48.12% (-5.61%) [Q4]

6% less funds holding

Funds holding: 86 [Q3] → 81 (-5) [Q4]

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

43% less capital invested

Capital invested by funds: $64.8M [Q3] → $36.9M (-$27.9M) [Q4]

97% less call options, than puts

Call options by funds: $2K | Put options by funds: $66K

Research analyst outlook

We haven’t received any recent analyst ratings for MASS.

Financial journalist opinion

Negative
Zacks Investment Research
1 week ago
5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
The tech-focused Nasdaq officially entered bear market territory on Friday, falling over 20% from its December peak.
5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
Positive
Zacks Investment Research
2 weeks ago
New Strong Buy Stocks for April 1st
AFRM, TKOMY, FOLD, MASS and VFC have been added to the Zacks Rank #1 (Strong Buy) List on April 1, 2025.
New Strong Buy Stocks for April 1st
Positive
Zacks Investment Research
1 month ago
Best Momentum Stocks to Buy for March 13th
BK, TKOMY and MASS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 13, 2025.
Best Momentum Stocks to Buy for March 13th
Neutral
Business Wire
1 month ago
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces that it has received a $1.7 million order from the Ministry of Health of Ukraine for its MX908 handheld mass spectrometry device with Aero module for priority shipment in the first quarter 2025. The devices will be part of an environmental testing kit in a post-war environment and will be used primarily to detect and identify trace substances of hazardous materi.
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
Positive
Seeking Alpha
1 month ago
908 Devices Makes Key Divestiture (Rating Upgrade)
908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device business, expecting 11% to 15% revenue growth in 2025 with acceleration in 2026. MASS management believes losses will be significantly reduced with the new structure, with positive cash flow next year.
908 Devices Makes Key Divestiture (Rating Upgrade)
Positive
Benzinga
1 month ago
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
On Tuesday, Repligen Corporation RGEN purchased 908 Devices Inc.'s MASS desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Negative
Zacks Investment Research
1 month ago
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.23 per share a year ago.
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
Neutral
Business Wire
1 month ago
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ended December 31, 2024. Strategic Transformation Realized 908 Devices cements its unique position as a market-leading provider of analytical tools for tackling critical public health and safety crises through the divestiture of its bioprocessing desktop assets to Repligen Corporation. This transac.
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
Neutral
Business Wire
1 month ago
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for chemical analysis, announce that Repligen has purchased 908 Devices' desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded handheld device.
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
Neutral
Business Wire
1 month ago
908 Devices to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor conferences. TD Cowen 45th Annual Healthcare Conference, Boston, MA Fireside chat on Wednesday, March 5 at 9:50 a.m. Eastern Time Leerink Global Healthcare Conference, Miami, FL Fireside chat on Tuesday, March 11 at 1 p.m. Eastern Time Interested parties may access a live and archived webcast of the.
908 Devices to Participate in Upcoming Investor Conferences
Charts implemented using Lightweight Charts™